Bg pattern

CINQAERO 10 mg/mL concentrate for infusion solution

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CINQAERO 10 mg/mL concentrate for infusion solution

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

CINQAERO 10mg/ml concentrate for solution for infusion

reslizumab

Read all of this leaflet carefully before you start receiving this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. See section 4.

Contents of the pack

  1. What is CINQAERO and what is it used for
  2. What you need to know before you receive CINQAERO
  3. How CINQAERO is administered
  4. Possible side effects
  5. Storage of CINQAERO
  6. Contents of the pack and further information

1. What is CINQAERO and what is it used for

What is CINQAERO

CINQAERO contains the active substance reslizumab, a monoclonal antibody, a type of protein that recognizes and binds to a specific target substance in the body.

What CINQAERO is used for

CINQAERO is used to treat severe eosinophilic asthma in adult patients (18 years of age or older) when the disease is not well controlled despite treatment with high-dose inhaled corticosteroids along with another asthma medication. Eosinophilic asthma is a type of asthma in which patients have too many eosinophils in the blood or lungs. CINQAERO is used in combination with other asthma medications (inhaled corticosteroids plus other asthma medications).

How CINQAERO works

CINQAERO blocks the activity of interleukin-5 and reduces the number of eosinophils present in the blood and lungs. Eosinophils are white blood cells (leukocytes) that are involved in asthma inflammation. Interleukin-5 is a protein made by the body that plays an essential role in asthma inflammation caused by the activation of eosinophils.

Benefits of using CINQAERO

CINQAERO reduces the frequency with which you may experience asthma exacerbations, helps you breathe better, and reduces asthma symptoms.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you receive CINQAERO

You must not receive CINQAERO:

  • if you are allergic to reslizumab or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or nurse before starting treatment with CINQAERO:

  • if you have a parasitic infection or if you live in an area where parasitic infections are common or if you are traveling to such an area, as this medicine may weaken your body's ability to fight certain types of parasitic infections.

Also, talk to your doctor or nurse while you are receiving CINQAERO:

  • if your asthma remains uncontrolled or worsens during treatment with this medicine;
  • if you experience any symptoms of an allergic reaction (e.g., itching, breathing problems, wheezing [a whistling sound when breathing], fever, chills, dizziness, headache, nausea, vomiting, abdominal discomfort, skin rash, redness, or swelling). Serious allergic reactions have occurred in patients treated with this medicine (see section "4. Possible side effects").

Children and adolescents

This medicine is NOT indicated for use in children and adolescents under 18 years of age.

Other medicines and CINQAERO

Tell your doctor if you are using, have recently used, or might use any other medicines.

This is especially important:

  • if you are taking other medicines that affect the immune system;
  • if you have recently received a vaccine or if you are likely to need a vaccine.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before receiving this medicine.

The active substance of this medicine may pass into breast milk, but only during the first few days after delivery.

Driving and using machines

CINQAERO is unlikely to affect your ability to drive and use machines.

CINQAERO contains sodium

This medicine contains 4.6 mg of sodium (main component of cooking/table salt) per 10 ml vial and 1.15 mg of sodium per 2.5 ml vial. This is equivalent to 0.23% and 0.06%, respectively, of the maximum recommended daily sodium intake for an adult.

3. How CINQAERO is administered

Follow the instructions given by your doctor exactly. If you are unsure, consult your doctor again.

The dose depends on your body weight. Your doctor will calculate the correct dose for you. The maximum dose is 3 mg per kilogram of body weight. CINQAERO will be administered every 4 weeks. A doctor or nurse will administer CINQAERO as an infusion (drip) into a vein. The infusion will take about 20 to 50 minutes.

Your doctor or nurse will closely monitor you during and after the infusion for signs of an allergic reaction.

If a scheduled dose of CINQAERO is missed

If a scheduled dose of CINQAERO is missed, ask your doctor when to schedule your next treatment.

If treatment with CINQAERO is interrupted

DO NOT interrupt treatment with CINQAERO unless your doctor tells you to, even if you feel better. Stopping or suspending treatment with this medicine may cause asthma symptoms to return.

If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

  • Severe allergic reactions

Severe allergic reactions may occur rarely (may affect up to 1 in 100 people) during administration of CINQAERO or after. Your doctor or nurse will closely monitor you for signs of a reaction. Consult your doctor or nurse immediatelyif you have any symptoms of an allergic reaction (e.g., itching, breathing problems, wheezing [a whistling sound when breathing], fever, chills, dizziness, headache, nausea, vomiting, abdominal discomfort, skin rash, redness, or swelling).

Other side effects

Common (may affect up to 1 in 10 people)

  • Increased blood enzyme (blood creatine phosphokinase).

Uncommon (may affect up to 1 in 100 people)

  • Muscle pain (myalgia).

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of CINQAERO

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after EXP. The expiry date refers to the last day of the month shown.

Store in a refrigerator (2°C to 8°C). Do not freeze.

Keep the vial in the outer carton to protect it from light.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and further information

Composition of CINQAERO

  • The active substance is reslizumab.

Each milliliter of concentrate contains 10 mg of reslizumab (10 mg/ml). Each 2.5 ml vial contains 25 mg of reslizumab and each 10 ml vial contains 100 mg of reslizumab.

  • The other excipients are sodium acetate trihydrate, glacial acetic acid, sucrose, and water for injections.

Appearance and pack of the product

CINQAERO is a concentrate for solution for infusion (sterile concentrate) that is between transparent and slightly turbid opalescent, and between colorless and slightly yellowish. It may contain proteinaceous particles that appear as translucent to white amorphous particles, some of which may have a fibrous appearance. This is not uncommon for proteinaceous solutions. The concentrate should not be used if it has a color (except slightly yellowish) or if it contains foreign particles.

CINQAERO is available in packs containing 1 or 2 vials of 2.5 ml and packs containing 1 or 2 vials of 10 ml.

Not all pack sizes may be marketed.

Marketing authorization holder

Teva B.V.

Swensweg 5

2031 GA Haarlem

Netherlands

Manufacturer

UAB Teva Baltics

Moletu pl. 5

LT-08409 Vilnius

Lithuania

Merckle GmbH

Graf-Arco-Str. 3

89079 Ulm

Germany

You can request more information about this medicine from the local representative of the marketing authorization holder:

België/Belgique/Belgien

Teva Pharma Belgium N.V./S.A./AG

Tél/Tel: +32 38207373

Lietuva

UAB Teva Baltics

Tel: +370 52660203

????????

???? ????? ???Tel: +359 24899585

Luxembourg/Luxemburg

Teva Pharma Belgium N.V./S.A./AG, Belgique/Belgien

Tél/Tel: +32 38207373

Ceská republika

Teva Pharmaceuticals CR, s.r.o.

Tel: +420 251007111

Magyarország

Teva Gyógyszergyár Zrt.

Tel.: +36 12886400

Danmark

Teva Denmark A/S

Tlf: +45 44985511

Malta

Teva Pharmaceuticals Ireland, L-Irlanda

Tel: +44 2075407117

Deutschland

TEVA GmbH

Tel: +49 73140208

Nederland

Teva Nederland B.V.

Tel: +31 8000228400

Eesti

UAB Teva Baltics Eesti filiaal

Tel: +372 6610801

Norge

Teva Norway AS

Tlf: +47 66775590

Ελλ?δα

Specifar A.B.E.E.Τηλ: +30 2118805000

Österreich

ratiopharm Arzneimittel Vertriebs-GmbH

Tel: +43 1970070

España

Teva Pharma, S.L.U.

Tel: +34 913873280

Polska

Teva Pharmaceuticals Polska Sp. z o.o.

Tel: +48 223459300

France

Teva Santé

Tél: +33 155917800

Portugal

Teva Pharma - Produtos Farmacêuticos, Lda

Tel: +351 214767550

Hrvatska

Pliva Hrvatska d.o.o.

Tel: +385 13720000

România

Teva Pharmaceuticals S.R.L

Tel: +40 212306524

Ireland

Teva Pharmaceuticals Ireland

Tel: +44 2075407117

Slovenija

Pliva Ljubljana d.o.o.

Tel: +386 15890390

Ísland

Teva Pharma Iceland ehf

Sími: +354 5503300

Slovenská republika

TEVA Pharmaceuticals Slovakia s.r.o.

Tel: +421 257267911

Italia

Teva Italia S.r.l.

Tel: +39 028917981

Suomi/Finland

Teva Finland Oy

Puh/Tel: +358 201805900

Κ?προς

Specifar A.B.E.E.

Ελλ?δα

Τηλ: +30 2118805000

Sverige

Teva Sweden AB

Tel: +46 42121100

Latvija

UAB Teva Baltics filiale Latvija

Tel: +371 67323666

United Kingdom (Northern Ireland)

Teva Pharmaceuticals Ireland

Ireland

Tel: +44 2075407117

Date of last revision of this leaflet:

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.

--------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

CINQAERO is supplied as a concentrate for solution for infusion in a single-use vial. The infusion solution is intended for intravenous use only after dilution and should be prepared using an aseptic technique as described below:

Traceability

In order to improve the traceability of biological medicinal products, the name and batch number of the administered product should be clearly recorded.

Preparation of the infusion solution

  1. Remove CINQAERO from the refrigerator. Do not shake the vial.
  2. The medicine should be inspected visually before use. The concentrate is between transparent and slightly turbid opalescent, and between colorless and yellowish. The concentrate may contain proteinaceous particles that appear as translucent to white amorphous particles, some of which may have a fibrous appearance. This is not uncommon for proteinaceous solutions. The concentrate should not be used if it has a color (except slightly yellowish) or if it contains foreign particles.
  3. A suitable injection syringe should be used to withdraw the required amount of concentrate from the vial(s) (see section 4.2 of the Summary of Product Characteristics or Package Leaflet).
  4. Slowly transfer the contents of the syringe(s) to an infusion bag containing 50 ml of infusion solution (9 mg/ml (0.9%) sodium chloride). Gently invert the bag to mix the solution. This medicine should not be mixed with other medicines except for a 9 mg/ml (0.9%) sodium chloride infusion solution.
  5. Discard any remaining concentrate in the vial.
  6. The infusion solution should be administered immediately after preparation. CINQAERO solutions diluted in 9 mg/ml (0.9%) sodium chloride infusion solution can be stored refrigerated at 2°C to 8°C (or not above 25°C if the dilution has taken place in controlled and validated aseptic conditions) and protected from light for up to 16 hours.
  7. CINQAERO is compatible with infusion bags made of polyvinyl chloride (PVC) or polyolefin (PO).

Administration instructions

  1. CINQAERO should be administered by a healthcare professional prepared to treat hypersensitivity reactions, including anaphylaxis (see section 4.4 of the Summary of Product Characteristics or Package Leaflet). The patient should be monitored during the entire infusion and for an appropriate period after the infusion. Patients should be instructed on how to recognize the symptoms of severe allergic reactions.
  2. If the infusion solution has been stored in a refrigerator, allow it to reach room temperature (15°C to 25°C).
  3. The infusion solution should be administered intravenously over 20-50 minutes. The infusion time may vary depending on the total volume to be administered.
  4. The infusion solution should not be administered concomitantly in the same intravenous line with other medicines. No physical or biochemical compatibility studies have been conducted to evaluate the co-administration of reslizumab with other medicines.
  5. An in-line filter with a pore size of 0.2 µm should be used for the infusion. CINQAERO is compatible with low protein-binding in-line filters made of polyethersulfone (PES), polyvinylidene fluoride (PVDF), nylon, and cellulose acetate.
  6. After the infusion is complete, flush the infusion set with a sterile 9 mg/ml (0.9%) sodium chloride infusion solution to ensure that all of the CINQAERO infusion solution has been administered.

See section 4.2 of the Summary of Product Characteristics or Package Leaflet for instructions related to dosage.

Online doctors for CINQAERO 10 mg/mL concentrate for infusion solution

Discuss questions about CINQAERO 10 mg/mL concentrate for infusion solution, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (100)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

5.0 (86)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

0.0 (15)
Doctor

Lizaveta Trafimchuk Takhvaniuk

Dermatology 10 years exp.

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

5.0 (1245)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
5.0 (196)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

5.0 (56)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.

Get CINQAERO 10 mg/mL concentrate for infusion solution Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for CINQAERO 10 mg/mL concentrate for infusion solution?

CINQAERO 10 mg/mL concentrate for infusion solution requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in CINQAERO 10 mg/mL concentrate for infusion solution?

The active ingredient in CINQAERO 10 mg/mL concentrate for infusion solution is reslizumab. This information helps identify medicines with the same composition but different brand names.

Who manufactures CINQAERO 10 mg/mL concentrate for infusion solution?

CINQAERO 10 mg/mL concentrate for infusion solution is manufactured by Teva B.V.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of CINQAERO 10 mg/mL concentrate for infusion solution online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CINQAERO 10 mg/mL concentrate for infusion solution is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy CINQAERO 10 mg/mL concentrate for infusion solution in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy CINQAERO 10 mg/mL concentrate for infusion solution in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to CINQAERO 10 mg/mL concentrate for infusion solution?

Other medicines with the same active substance (reslizumab) include DAXAS 250 micrograms tablets, DAXAS 500 micrograms FILM-COATED TABLETS, FASENRA 30 mg Injectable Solution in Pre-filled Syringe. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media